Team

Dr. Gottfried Musil – Managing Director
Dr. Gottfried Musil serves as Managing Director of Bio&Bio and is responsible for the company’s overall strategy, operations, and partnering activities. He brings extensive experience in managing organizations and represents Bio&Bio to industrial, licensing, and strategic partners. His leadership ensures a structured, transparent, and reliable framework for collaboration.

Dr. Johann Graus – Chief Scientific Officer

Dr. Johann Graus serves as Chief Scientific Officer of Bio&Bio and brings extensive expertise in coagulation science and plasma-derived therapies. He has been closely involved in the scientific strategy and development of Prethrombin-1 and contributes deep domain knowledge across research and translational development.

Isabell Eibl-Markl – Shareholder & Capital Representative
Isabell Eibl-Markl is shareholder of Bio&Bio and represents the capital side of the company. She safeguards the long-term strategic and financial interests of Bio&Bio and supports the company’s partnering activities with a focus on sustainable value creation. She serves as a key contact for ownership, capital structure, and strategic alignment.